Investigation Report on China's Tocilizumab Market 2021-2025
SKU ID :CRI-18360566 | Published Date: 28-May-2021 | No. of pages: 50Description
TOC
Table of Contents
1 Relevant Concept of Tocilizumab
1.1 Indications for Tocilizumab
1.2 Development of Tocilizumab in China
1.3 Governmental Approval of Tocilizumab in China
1.4 The Impact of COVID-19 on Tocilizumab sales in China
2 Sales of Tocilizumab in China, 2016-2020
2.1 Sales Value of Tocilizumab
2.1.1 Overall Sales Value
2.1.2 Sales Value by Regions
2.2 Sales Volume of Tocilizumab
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Tocilizumab by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Forms
3 Analysis of Major Tocilizumab Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Tocilizumab Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Roche Pharma (Schweiz) AG
3.2.1 Enterprise Profile
3.2.2 Sales of ACTEMRA (Roche Pharma (Schweiz) AG's Tocilizumab) in China
4 Prices of Tocilizumab for Different Manufacturers in China, 2020-2021
4.1 Roche Pharma (Schweiz) AG (ACTEMRA)
4.2 Others
5 Prospect of Chinese Tocilizumab Market, 2021-2025
5.1 Influential Factors of Chinese Tocilizumab Market Development
5.1.1 The Impact of COVID-19 on Chinese Tocilizumab Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Tocilizumab Injection Registration in China
Chart Sales Value of Tocilizumab Injection over the World
Chart Sales Value of Tocilizumab Injection in China, 2016-2020
Chart Sales Value of Tocilizumab Injection in China by Regions, 2016-2020
Chart Sales Volume of Tocilizumab Injection in China, 2016-2020
Chart Sales Volume of Tocilizumab Injection in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Tocilizumab Manufacturers in China, 2016-2020
Chart Sales Value and Volume of ACTEMRA in China, 2016-2020
Chart Referential Prices of ACTEMRA in China by regions, 2020-2021
Chart Forecast on Sales Value of Tocilizumab in China, 2021-2025
Chart Forecast on Sales Volume of Tocilizumab in China, 2021-2025
Tables & Figures
Companies
- PRICE
-
$2600$3900